excursion post-meal. If canagliflozin does delay intestinal
glucose absorption due to transiently high intraluminal drug
concentrations, administering an additional dose of canagliflozin
300 mg just prior to the meal would further lower the glucose
excursion, relative to administration only 24 hours prior to the
meal. To evaluate the dose response for a non-renal mechanism,
which would be expected to be different from the dose
response for renal SGLT2 inhibition, the present study included
doses of 150 and 300 mg based on the previous observation
suggesting effects of canagliflozin on gut glucose absorption at
doses >200 mg, but not at lower doses